OUE Lippo Healthcare posts net loss of $4.01m in H2 22

For fiscal year 2022, its revenue grew to $119.8m YoY.

Healthcare group, OUE Lippo Healthcare, recorded a revenue of almost $120m in FY 2022, compared to $19.7m in FY 2021.

In its financial statement, its revenue increased to $77.194m in FY 2022 from $9m in FY 2021.

OUE Lippo Healthcare, however, reported a net loss of $4.01m in the second half of 2022.

For the full year that ended 31 December 2022, its profit after tax was at $32.5m in FY 2022 from $110.9m in the same period in 2021.

Higher revenue stemmed from its consolidation of first REIT and medical partners from 1 March last year and from 1 July last year and Wuxi Lippo Xi Nan hospital and the China pharmaceutical distribution business revenue growth.

Follow the link for more news on

OUE Lippo Healthcare

Financial Statements

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia